Case number 3:18-cv-13905
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. ALKEM LABORATORIES LTD. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 15, 2019 | 16 | Order (7) Docket Text: ORDER CONSOLIDATING CASES FOR ALL PURPOSES. Civil Action No. 18-13635 shall be the Lead Case and effective upon entry of this order, all filings in the Consolidated Actions are to be made only in Civil Action No. 18-13635. Signed by Judge Peter G. Sheridan on 4/15/2019. (mmh) |
| Apr 15, 2019 | N/A | Terminated Case (0) Docket Text: ***Civil Case Administratively Terminated. (mmh) |
| Mar 21, 2019 | N/A | Pretrial Conference - Initial (0) Docket Text: Text Minute Entry for proceedings held before Magistrate Judge Lois H. Goodman: Initial Pretrial Conference held on 3/21/2019 via Conference Call. (if, ) |
| Mar 5, 2019 | 15 | Answer to Counterclaim (12) |
| Mar 5, 2019 | 15 | Main Document (12) Docket Text: ANSWER to Counterclaim by DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC. (Attachments: # (1) Certificate of Service)(DENI, WILLIAM) |
| Mar 5, 2019 | 15 | Certificate of Service (2) |
| Feb 22, 2019 | 14 | Order (5) Docket Text: ORDER SCHEDULING CONFERENCE. Scheduling Conference set for 3/21/2019 10:00 AM in Trenton - Courtroom 7E before Magistrate Judge Lois H. Goodman. Signed by Magistrate Judge Lois H. Goodman on 2/22/2019. (mmh) |
| Feb 20, 2019 | N/A | Update Answer Due Deadline (0) Docket Text: Clerk`s Text Order - The document [13] Application for Clerk's Order to Ext Answer/Proposed Order, submitted by DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC has been GRANTED. The answer due date has been set for 3/5/2019. (mmh) |
| Feb 19, 2019 | 13 | Application for Clerk's Order to Ext Answer/Proposed Order (2) Docket Text: Application and Proposed Order for Clerk's Order to extend time to answer as to Plaintiffs Valeant Pharmaceuticals North America LLC, Valeant Pharmaceuticals Ireland Ltd., Dow Pharmaceutical Sciences, Inc., and Kaken Pharmaceutical Co., Ltd... (DENI, WILLIAM) |
| Jan 28, 2019 | 12 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by JAMES P. BARABAS on behalf of ALKEM LABORATORIES LTD. (BARABAS, JAMES) |
| Jan 28, 2019 | 11 | Corporate Disclosure Statement (aty) (3) Docket Text: Corporate Disclosure Statement by ALKEM LABORATORIES LTD.. (RODRIGUEZ, FRANK) |
| Jan 28, 2019 | 10 | Answer to Complaint (30) Docket Text: ANSWER to Complaint , COUNTERCLAIM against DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC by ALKEM LABORATORIES LTD..(RODRIGUEZ, FRANK) |
| Dec 18, 2018 | 9 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by JUSTIN JAMES HASFORD on behalf of KAKEN PHARMACEUTICAL CO., LTD. (HASFORD, JUSTIN) |
| Dec 11, 2018 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. ALKEM LABORATORIES LTD. waiver sent on 11/28/2018, answer due 2/26/2019. (LOWER, J.) |
| Dec 5, 2018 | 7 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by J. BRUGH LOWER on behalf of DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC (LOWER, J.) |
| Sep 17, 2018 | N/A | Add and Terminate Judges (0) Docket Text: Judge Peter G. Sheridan and Magistrate Judge Lois H. Goodman added. (jjc, ) |
| Sep 14, 2018 | 6 | Summons Issued (2) Docket Text: SUMMONS ISSUED as to ALKEM LABORATORIES LTD. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jmh) |
| Sep 14, 2018 | 1 | Complaint (23) |
| Sep 14, 2018 | 5 | AO120 Patent/Trademark Form (1) Docket Text: AO120 Patent Form filed. (jmh) |
| Sep 14, 2018 | 4 | AO120 Patent/Trademark Form (1) Docket Text: AO120 Patent Form filed. (jmh) |
| Sep 14, 2018 | 3 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by KAKEN PHARMACEUTICAL CO., LTD. identifying none as Corporate Parent.. (DENI, WILLIAM) |
| Sep 14, 2018 | 2 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC identifying Bausch Health Companies Inc. as Corporate Parent.. (DENI, WILLIAM) |
| Sep 14, 2018 | 1 | L. Civ. R. 11.2 Certification (2) |
| Sep 14, 2018 | 1 | Civil Cover Sheet (1) |
| Sep 14, 2018 | 1 | Exhibit H (11) |
| Sep 14, 2018 | 1 | Exhibit G (17) |
| Sep 14, 2018 | 1 | Exhibit F (14) |
| Sep 14, 2018 | 1 | Exhibit E (11) |
| Sep 14, 2018 | 1 | Exhibit D (17) |
| Sep 14, 2018 | 1 | Exhibit C (17) |
| Sep 14, 2018 | 1 | Exhibit B (16) |
| Sep 14, 2018 | 1 | Main Document (23) Docket Text: COMPLAINT against ALKEM LABORATORIES LTD. ( Filing and Admin fee $ 400 receipt number 0312-9025442), filed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Civil Cover Sheet, # (10) L. Civ. R. 11.2 Certification)(DENI, WILLIAM) |
| Sep 14, 2018 | 1 | Exhibit A (15) |
| Sep 14, 2018 | 1 | Complaint* (1) |
